Medi-Cal coverage of weight loss drugs on chopping block under governor’s proposal - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Health/Employee Benefits News
Newswires RSS Get our newsletter
Order Prints
May 16, 2025 Newswires
Share
Share
Post
Email

Medi-Cal coverage of weight loss drugs on chopping block under governor’s proposal

ANA B. IBARRA CalMattersImperial Valley Press

Popular weight loss drugs Ozempic and Wegovy would no longer be covered by Medi-Cal under a proposal unveiled by Gov. Gavin Newsom Wednesday in an effort to reduce cost overruns in the state health insurance program.

The costly drugs prescribed to fight obesity have been driving up the cost of Medi-Cal, the state program that provides health coverage for low-income Californians. Eliminating coverage for these drugs would save the state $85 million in 2025-26, and up to $680 million by 2028-29, according to the governor's office.

Newsom's proposal will be taken up by the state Legislature as the governor and top legislators tackle a state budget facing a $12 billion deficit.

As proposed, coverage of the drugs would end on Jan. 1, 2026. Medi-Cal patients trying to lose weight would have to pay for the prescriptions themselves, at a cost of more than $1,000 per month, making it unattainable for low-income people.

Some health professionals say the drugs are highly effective at combating obesity, a chronic disease that drives up health care costs because it can lead to many other disorders such as heart disease and diabetes.

An estimated 18 million adults in California are obese or overweight, according to the UCLA Center for Health Policy Research.

"This is a bad decision. The people who are already taking this medication, what's going to happen to them?" said Liz Helms, president of the California Chronic Care Coalition, a group of health consumer advocacy organizations and providers.

Dr. Wayne Ho, a Los Angeles obesity specialist and researcher, said patients will likely regain the weight they've lost, and also lose the health benefits they've gained, such as lower blood pressure and cholesterol.

"It is the best tool I have had as a primary care physician in practicing preventative medicine," Ho said of weight management drugs. For patients on Medi-Cal, he said it can be especially difficult to access obesity specialists and nutritious foods, making their weight loss journey even more difficult.

On the other hand, the California Association of Health Plans said Newsom's proposal "should send a strong signal to the Legislature that they should reconsider mandating that health plans cover these costly drugs for weight loss without the proper clinical safeguards in place."

California is not required by federal law to cover the cost of the weight loss drugs in its Medi-Cal program. Instead, the state opted to include them. Under Newsom's proposed cuts, when Ozempic is prescribed to treat diabetes, it would still be covered by Medi-Cal.

Newsom's proposal comes as Wegovy and Ozempic prescriptions among Medi-Cal enrollees are soaring along with overall prescription drug spending. In fiscal year 2023-24, drugs cost Medi-Cal close to $15.2 billion, according to state drug cost reports. That's about a 10% increase from the previous year.

Between 2022 and 2023, Wegovy prescriptions in the Medi-Cal program jumped from 15,000 to 181,000, data from the U.S. Centers for Medicaid and Medicare Services show. Ozempic prescriptions for diabetes and weight loss rose from 178,000 in 2022 to 480,000 in 2023.

In 2023, the latest year for which data is available, Medi-Cal spent about $733 million on both drugs. (This amount does not include the refunds that Medi-Cal received from pharmaceutical companies as part of rebate programs.)

In his budget presentation today, Newsom did not mention the drugs. But he said the state had to "tighten things up" in its massive Medi-Cal program so he proposed several restrictions, including a freeze on Medi-Cal enrollments by people who lack permanent legal immigration status. Medi-Cal covers nearly 15 million Californians.

Earlier this year, the state had to backfill a $6.2 billion shortfall in its Medi-Cal budget to pay providers through the end of June. The Department of Health Care Services, which oversees the Medi-Cal program, cited a number of reasons for going over budget, including the state's expansion to undocumented immigrants and an increase in prescription drug spending.

Ozempic is primarily used to treat Type 2 diabetes, but some doctors prescribe it for weight loss, too. Wegovy is used only for weight loss. Both are manufactured by Danish pharmaceutical company Novo Nordisk, and there are no generic versions.

Semaglutide, the active ingredient in both drugs, works by mimicking the GLP-1 hormone, which helps regulate blood sugar and appetite. In an attempt to contain costs, Medi-Cal already limits the quantity of Wegovy that can be dispensed every 28 days to one carton of four pen injectors. Patients inject themselves once a week.

To qualify for Medi-Cal, a single person's annual income cannot exceed $21,597. For a family of 4, the threshold is $44,367.

Erica Yee contributed to this report.

Older

Wisconsin advocates worry federal plan to increase Medicaid paperwork will lead to lost coverage

Newer

Iowa lawmakers pass bill banning Medicaid coverage for gender-affirming care

Advisor News

  • NAIFA applauds final SECURE 2.0 regulations
  • What will Democrats in Congress do about healthcare and retirement?
  • Election results cloud retirement legislation outlook, experts say
  • Planning for the missing chapter
  • Semi-retirement: helping clients balance flexibility with financial security
More Advisor News

Annuity News

  • ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
  • Jackson Launches Direct-to-Consumer Annuity Offering
  • Global Atlantic launches ForeIncome Flex
  • Athene CEO criticizes offshore reinsurance, risk-taking by competitors
  • DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
More Annuity News

Health/Employee Benefits News

  • Medicaid work rules don’t apply to Native Americans. They could still lose coverage.
  • Oscar Highlights Tailored New Health Products in Florida for 2027 Open Enrollment
  • Oscar Highlights Tailored New Health Products in Texas for 2027 Open Enrollment
  • States get until July to cut Medicaid coverage over work requirement
  • CRUSH Rule could crush health insurance agents, industry group says
More Health/Employee Benefits News

Life Insurance News

  • Best’s Commentary: Shanghai Cross-Border Investment Pilot Unlocks Overseas Growth Potential of China Non-Life Companies
  • Military Briefs: November 19-25
  • California’s new solvency rules: What should life insurance advisors watch?
  • Navigating delayed death certificates: A guide for life insurance advisors
  • Jackson Launches Direct-to-Consumer Annuity Offering
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • OpenRoad Insurance Data Shows 40% of Collector Vehicles Are Model Year 1980 or Newer
  • Insurvoice Lets Independent Insurance Agency Owners Analyze Every Customer Call in ChatGPT or Claude
  • Spectrum Weather & Specialty Insurance Celebrates 15 Years and Welcomes the Next Generation
  • Royal Neighbors of America® Increases Service Capacity
  • Benefits Studio Launches to Fill the Missing Middle of Benefits Navigation at $49/mo
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.